Jonathan Kopel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jonathan Kopel has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
A. Baugham
Department of Neurology. Covenant Medical Center, Lubbock, TX, United States
1 shared publication- Abdul Naji Hamood
Department of Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
1 shared publication - Chanaka Nadeeshan Kahathuduwa
Department of Neurology, Texas Tech University Health Sciences Center, Lubbock (P.S., M.V., C.K., Saif Bushnaq)
1 shared publication - David J. Westenberg
Department of Biological Sciences, Missouri University of Science and Technology
1 shared publication - G. Neves
Department of Neurology. Texas Tech University Health Science Center, Lubbock, TX, United States
1 shared publication - J. Curry
Emergency Medical Services, University Medical Center, Lubbock, TX, United States
1 shared publication
Latest Publications
- 9 July 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 244, 108442
The use of a pre-hospital questionnaire expedited the acute management of patients with ischemic stroke in a comprehensive stroke center
- 9 July 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 244, 108442
The use of a pre-hospital questionnaire expedited the acute management of patients with ischemic stroke in a comprehensive stroke center
- Open Access
- 17 December 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (12) , 1838
An Assessment of the In Vitro Models and Clinical Trials Related to the Antimicrobial Activities of Phytochemicals
An increased number antibiotic-resistant bacteria have emerged with the rise in antibiotic use worldwide. As such, there has been a growing interest in investigating novel antibiotics against antibiotic-resistant bacteria. Due to the extensive history of using plants for medicinal purposes, scientists and medical professionals have turned to plants as potential alternatives to common antibiotic treatments. Unlike other antibiotics in use, plant-based antibiotics have the innate ability to eliminate a broad spectrum of microorganisms through phytochemical defenses, including compounds such as alkaloids, organosulfur compounds, phenols, coumarins, and terpenes. In recent years, these antimicrobial compounds have been refined through extraction methods and tested against antibiotic-resistant strains of Gram-negative and Gram-positive bacteria. The results of the experiments demonstrated that plant extracts successfully inhibited bacteria independently or in combination with other antimicrobial products. In this review, we examine the use of plant-based antibiotics for their utilization against antibiotic-resistant bacterial infections. In addition, we examine recent clinical trials utilizing phytochemicals for the treatment of several microbial infections.
- 17 December 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (12) , 1838
Open AccessAn Assessment of the In Vitro Models and Clinical Trials Related to the Antimicrobial Activities of Phytochemicals
An increased number antibiotic-resistant bacteria have emerged with the rise in antibiotic use worldwide. As such, there has been a growing interest in investigating novel antibiotics against antibiotic-resistant bacteria. Due to the extensive history of using plants for medicinal purposes, scientists and medical professionals have turned to plants as potential alternatives to common antibiotic treatments. Unlike other antibiotics in use, plant-based antibiotics have the innate ability to eliminate a broad spectrum of microorganisms through phytochemical defenses, including compounds such as alkaloids, organosulfur compounds, phenols, coumarins, and terpenes. In recent years, these antimicrobial compounds have been refined through extraction methods and tested against antibiotic-resistant strains of Gram-negative and Gram-positive bacteria. The results of the experiments demonstrated that plant extracts successfully inhibited bacteria independently or in combination with other antimicrobial products. In this review, we examine the use of plant-based antibiotics for their utilization against antibiotic-resistant bacterial infections. In addition, we examine recent clinical trials utilizing phytochemicals for the treatment of several microbial infections.
- Open Access
- 2 December 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (12) , 1742
An Initial Report of the Antimicrobial Activities of Volatiles Produced during Rapid Volatilization of Oils
Aerosols generated through volatilization and subsequent recondensation of oil vapors have been used as obscurant (smoke) screens during military operations since the early twentieth century. Specifically, a petroleum middle distillate known as the fog oil (FO) has been used in US military battlefields to create obscurant smoke screens. During a study on the feasibility of replacing petroleum-derived FO with vegetable oil-derived esters such as methyl soyate (MS), it was observed that that FO and MS aerosols and vapors did not exhibit detectable mutagenic activity but were lethal to Ames strains bacteria even after very short exposure periods. These results opened the potential use of oil-derived vapors as antimicrobial agents. Subsequent studies showed that optimal aerosol/vapor production conditions could further enhance disinfectant efficiency. For this purpose, we examined the antimicrobial activities of mineral oils and biogenic oil ester aerosols/vapors against a wide range of Gram-positive and Gram-negative bacteria. The results of the study showed that the aerosols/vapors obtained from mineral oil or vegetable oil ester under proper conditions can serve as an excellent antibacterial disinfectant.
- 2 December 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (12) , 1742
Open AccessAn Initial Report of the Antimicrobial Activities of Volatiles Produced during Rapid Volatilization of Oils
Aerosols generated through volatilization and subsequent recondensation of oil vapors have been used as obscurant (smoke) screens during military operations since the early twentieth century. Specifically, a petroleum middle distillate known as the fog oil (FO) has been used in US military battlefields to create obscurant smoke screens. During a study on the feasibility of replacing petroleum-derived FO with vegetable oil-derived esters such as methyl soyate (MS), it was observed that that FO and MS aerosols and vapors did not exhibit detectable mutagenic activity but were lethal to Ames strains bacteria even after very short exposure periods. These results opened the potential use of oil-derived vapors as antimicrobial agents. Subsequent studies showed that optimal aerosol/vapor production conditions could further enhance disinfectant efficiency. For this purpose, we examined the antimicrobial activities of mineral oils and biogenic oil ester aerosols/vapors against a wide range of Gram-positive and Gram-negative bacteria. The results of the study showed that the aerosols/vapors obtained from mineral oil or vegetable oil ester under proper conditions can serve as an excellent antibacterial disinfectant.
- 13 October 2022
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 202, 106598
The efficacy of organo-selenium conjugated cellulose polymer dressing to inhibit Candida albicans biofilm formation
- 13 October 2022
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 202, 106598
The efficacy of organo-selenium conjugated cellulose polymer dressing to inhibit Candida albicans biofilm formation